Announcements Trials
Browse Landscape

Phase

Phase NA 38Phase 4 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Breast Neoplasms 277Neoplasms 202Prostatic Neoplasms 118Polycystic Ovary Syndrome 114Colorectal Neoplasms 104Carcinoma, Hepatocellular 103Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Stomach Neoplasms 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Pain 59Neoplasm Metastasis 54Multiple Myeloma 52Pancreatic Neoplasms 46Keratosis, Actinic 46Pain, Postoperative 43Head and Neck Neoplasms 43Leukemia, Myeloid, Acute 40Leiomyoma 39Recurrence 38Liver Neoplasms 38Colonic Neoplasms 37Uterine Cervical Neoplasms 35Lymphoma 35Brain Neoplasms 34Infertility 33Papillomavirus Infections 32Ovarian Neoplasms 31Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Medication Adherence × Clear all
NCT07630948 2026-06-05

riboADHERE

Institute of Oncology Ljubljana

Phase 4 Not yet recruiting
90 enrolled
Breast

Breast Neoplasms, Medication Adherence

NCT04479579 2022-04-22

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

McMaster University

Phase 4 Completed
53 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡